Progesterone receptor-positive breast cancer
Clinical trials for Progesterone receptor-positive breast cancer explained in plain language.
Never miss a new study
Get alerted when new Progesterone receptor-positive breast cancer trials appear
Sign up with your email to follow new studies for Progesterone receptor-positive breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a targeted drug boost hormone therapy against breast cancer?
Disease control CompletedThis trial is testing whether adding an experimental drug called BYL719 to standard hormone therapy (letrozole) can better fight hormone receptor-positive metastatic breast cancer in post-menopausal women. BYL719 targets a protein that helps cancer cells grow, while letrozole blo…
Matched conditions: PROGESTERONE RECEPTOR-POSITIVE BREAST CANCER
Phase 1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Could a short course of radiation before surgery spare more breast tissue?
Disease control CompletedThis pilot study tested whether giving a high dose of focused radiation (APBI) to the tumor before surgery is feasible for older women with early-stage, hormone-sensitive breast cancer. Twenty-two participants received radiation followed by a lumpectomy. The goal was to see if th…
Matched conditions: PROGESTERONE RECEPTOR-POSITIVE BREAST CANCER
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC